Inactivation of SARS-CoV-2 and COVID-19 Patient Samples for Contemporary Immunology and Metabolomics Studies

Due to the severity of COVID-19 disease, the U.S. Centers for Disease Control and Prevention and World Health Organization recommend that manipulation of active viral cultures of SARS-CoV-2 and respiratory secretions from COVID-19 patients be performed in biosafety level (BSL)3 laboratories. Therefo...

Descripción completa

Detalles Bibliográficos
Autores principales: Eddins, Devon J., Bassit, Leda C., Chandler, Joshua D., Haddad, Natalie S., Musall, Kathryn L., Yang, Junkai, Kosters, Astrid, Dobosh, Brian S., Hernández, Mindy R., Ramonell, Richard P., Tirouvanziam, Rabindra M., Lee, F. Eun-Hyung, Zandi, Keivan, Schinazi, Raymond F., Ghosn, Eliver E. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164212/
https://www.ncbi.nlm.nih.gov/pubmed/35173021
http://dx.doi.org/10.4049/immunohorizons.2200005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164212/
https://www.ncbi.nlm.nih.gov/pubmed/35173021
http://dx.doi.org/10.4049/immunohorizons.2200005

Ejemplares similares